Multiple Sclerosis – Roche CN45320

Profound Research is enrolling a Multiple Sclerosis (MS) study that is assessing an investigational medication to see if it potentially increases treatment access for people living with MS.

Participation is optional, see preliminary information below:

To be eligible to participate, you must:

• Be 18-65 years of age
• Be diagnosed with Relapsing-Remitting MS or Primary Progressive MS
• Have never taken mitoxantrone (Novantrone®)

Qualified participants will receive:

• Study-related care and investigational medication at no cost
• Financial compensation for time and travel may be available

Complete the form and our team will reach out soon to help determine your eligibility.